Daniel Camardo
Director/Board Member at CommunityHealth NFP
Net worth: 1 712 $ as of 2024-03-30
Profile
Daniel A.
Camardo is currently the Director at CommunityHealth NFP.
Previously, he held positions as the CEO, CFO, Secretary, Director & CAO at Athersys, Inc. in 2022, Senior Director-US Commercial Operations at Astellas Pharma US, Inc. in 2003-2004, Vice President-Sales & Operations at Clarus Therapeutics, Inc. in 2014-2015, and President-US & Executive Vice President at Horizon Therapeutics Plc in 2015-2022.
He obtained his undergraduate degree from Rochester Christian University and an MBA from Kellogg School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ATHERSYS, INC.
0.46% | 2023-10-03 | 285,341 ( 0.46% ) | 1 712 $ | 2024-03-30 |
Daniel Camardo active positions
| Companies | Position | Start |
|---|---|---|
| CommunityHealth NFP | Director/Board Member | - |
Former positions of Daniel Camardo
| Companies | Position | End |
|---|---|---|
| ATHERSYS, INC. | Chief Executive Officer | 2023-12-30 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 2022-01-31 |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Sales & Marketing | 2015-08-31 |
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Corporate Officer/Principal | 2003-12-31 |
Training of Daniel Camardo
| Rochester Christian University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ATHERSYS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Health Technology |
| CommunityHealth NFP |
- Stock Market
- Insiders
- Daniel Camardo
